Trial · NCT07903714
Hyperventilation and Post-Activation Performance Enhancement on Anaerobic Capacity
NCT07903714, Not applicable, Completed, Manisa Celal Bayar University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Hyperventilation and Post-Activation Performance Enhancement on Anaerobic Capacity. Trials, record NCT07903714. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07903714
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Hyperventilation and Post-Activation Performance Enhancement on Anaerobic Capacity
- NCT number
- NCT07903714
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 11 participants, actual
- Lead sponsor
- Manisa Celal Bayar University
- Conditions
- Anaerobic Performance, Energy System Contributions, Hyperventilation, Post Activation Potentiation
- Interventions
- Voluntary Hyperventilation, Post-Activation Performance Enhancement (PAPE), Wingate Anaerobic Test
- First posted
- 2026-10-29
- Last updated
- 2026-10-29
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Relative Peak Power (RPP) | During the 30-second Wingate anaerobic test | Evaluation of relative peak power during the 30-second Wingate anaerobic test |
| Primary | Relative Mean Power (RMP) | During the 30-second Wingate anaerobic test | Evaluation of relative mean power during the 30-second Wingate anaerobic test. |
| Primary | Fatigue Index (FI) | During the 30-second Wingate anaerobic test | Evaluation of fatigue index during the 30-second Wingate anaerobic test. |
| Secondary | ATP-PCr Energy System Contribution (Absolute) | During the 5-minute post-exercise recovery period | Evaluation of ATP-PCr energy system contribution in absolute terms (kJ), determined from the fast component of excess post-exercise oxygen consumption (EPOC) during recovery. |
| Secondary | ATP-PCr Energy System Contribution (Relative) | During the 5-minute post-exercise recovery period | Evaluation of ATP-PCr energy system contribution in relative terms (%), determined from the fast component of excess post-exercise oxygen consumption (EPOC) during recovery. |
| Secondary | Glycolytic Energy System Contribution (Absolute) | Pre-test and at the 5-minute post-test recovery | Evaluation of glycolytic energy system contribution in absolute terms (kJ), estimated using delta blood lactate concentration (Δ\[BLa\]) measured pre-test and post-test. |
| Secondary | Glycolytic Energy System Contribution (Relative) | Pre-test and at the 5-minute post-test recovery | Evaluation of glycolytic energy system contribution in relative terms (%), estimated using delta blood lactate concentration (Δ\[BLa\]) measured pre-test and post-test. |
| Secondary | Oxidative Energy System Contribution (Absolute) | During the 30-second Wingate anaerobic test | Evaluation of oxidative energy system contribution in absolute terms (kJ), calculated based on net oxygen volume consumed during the 30-second test (VO₂net). |
| Secondary | Oxidative Energy System Contribution (Relative) | During the 30-second Wingate anaerobic test | Evaluation of oxidative energy system contribution in relative terms (%), calculated based on net oxygen volume consumed during the 30-second test (VO₂net). |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07903714
GET https://conductscience.org/api/trials/v1/NCT07903714/registered